Indian Journal of Hematology and Blood Transfusion

, Volume 29, Issue 3, pp 173–177

Successful Management of Chronic Refractory Immune Thrombocytopenia with Laparoscopic Splenectomy in a Patient with Acute Promyelocytic Leukemia

  • Ahmet Emre Eskazan
  • Ayse Salihoglu
  • Emine Gulturk
  • Seniz Ongoren Aydin
  • Nukhet Tuzuner
  • Yildiz Aydin
Case Report
  • 89 Downloads

Abstract

Acute promyelocytic leukemia (APL) is a particular type of acute myeloid leukemia with characteristic biological and clinical features, the frequent association at diagnosis of a severe hemorrhagic diathesis. Immune thrombocytopenia (ITP) is a common autoimmune disease characterized by low platelet counts and an increased risk of bleeding. Here we present a patient with the diagnosis of APL who achieved and maintained a remission with an induction consisting of idarubicin and ATRA, and then developed corticosteroid refractory ITP which is successfully treated with laparoscopic splenectomy.

Keywords

Immune thrombocytopenia ITP Splenectomy Acute promyelocytic leukemia APL 

References

  1. 1.
    Warrell RP Jr, de The′ H, Wang Z-Y, Degos L (1993) Acute promyelocytic leukemia. N Engl J Med 329(3):177–189PubMedCrossRefGoogle Scholar
  2. 2.
    Grignani F, Fagioli M, Alcalay M, Longo L, Pandolfi PP, Dotti E, Biondi A, Lo Coco F, Grignani F, Pelicci PG (1994) Acute promyelocytic leukemia: from genetics to treatment. Blood 83(1):10–25PubMedGoogle Scholar
  3. 3.
    Tallman MS, Nabhan C, Feusner JH, Rowe JM (2002) Acute promyelocytic leukemia: evolving therapeutic strategies. Blood 99(3):759–767PubMedCrossRefGoogle Scholar
  4. 4.
    Arnold DM, Dentali F, Crowther MA, Meyer RM, Cook RJ, Sigouin C, Fraser GA, Lim W, Kelton JG (2007) Systematic review: efficacy and safety of rituximab for adults with idiopathic thrombocytopenic purpura. Ann Intern Med 146(1):25–33PubMedCrossRefGoogle Scholar
  5. 5.
    Bussel JB, Kuter DJ, George JN, McMillan R, Aledort LM, Conklin GT, Lichtin AE, Lyons RM, Nieva J, Wasser JS, Wiznitzer I, Kelly R, Chen CF, Nichol JL (2006) AMG 531, a thrombopoiesis-stimulating protein, for chronic ITP. N Engl J Med 355(16):1672–1681PubMedCrossRefGoogle Scholar
  6. 6.
    Sanz MA, Martín G, Rayón C, Esteve J, González M, Díaz-Mediavilla J, Bolufer P, Barragán E, Terol MJ, González JD, Colomer D, Chillón C, Rivas C, Gómez T, Ribera JM, Bornstein R, Román J, Calasanz MJ, Arias J, Alvarez C, Ramos F, Debén G (1999) A modified AIDA protocol with anthracycline-based consolidation results in high antileukemic efficacy and reduced toxicity in newly diagnosed PML/RARalpha-positive acute promyelocytic leukemia PETHEMA group. Blood 94(9):3015–3021PubMedGoogle Scholar
  7. 7.
    Taylor FB Jr, Toh CH, Hoots WK, Wada H, Levi M (2001) Scientific Subcommittee on Disseminated Intravascular Coagulation (DIC) of the International Society on Thrombosis and Haemostasis (ISTH). Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thromb Haemost 86(5):1327–1330PubMedGoogle Scholar
  8. 8.
    Aster RH, Curtis BR, McFarland JG, Bougie DW (2009) Drug-induced immune thrombocytopenia: pathogenesis, diagnosis, and management. J Thromb Haemost 7(6):911–918PubMedCrossRefGoogle Scholar
  9. 9.
    Aster RH, Bougie DW (2007) Drug-induced immune thrombocytopenia. N Engl J Med 357(6):580–587PubMedCrossRefGoogle Scholar
  10. 10.
    Gonzalez CE, Pengetze YM (2005) Post-transfusion purpura. Curr Hematol Rep 4(2):154–159PubMedGoogle Scholar
  11. 11.
    Abramson N, Eisenberg PD, Aster RH (1974) Post-transfusion purpura: immunologic aspects and therapy. N Engl J Med 291(22):1163–1166PubMedCrossRefGoogle Scholar
  12. 12.
    Horino S, Rikiishi T, Niizuma H, Abe H, Watanabe Y, Onuma M, Hoshi Y, Sasahara Y, Yoshinari M, Kazama T, Hayashi Y, Kumaki S, Tsuchiya S (2009) Refractory chronic immune thrombocytopenic purpura in a child with acute lymphoblastic leukemia. Int J Hematol 90(4):483–485PubMedCrossRefGoogle Scholar
  13. 13.
    Ashihara E, Shimazaki C, Hirata T, Okawa K, Oku N, Goto H, Inaba T, Fujita N, Nakagawa M (1993) Autoimmune thrombocytopenia following peripheral blood stem cell autografting. Bone Marrow Transplant 12(3):297–299PubMedGoogle Scholar
  14. 14.
    Fujita H, Togami K, Mori M, Hashimoto H, Nagai K, Nagai Y, Tabata S, Kurata M, Mastusita A, Maeda A, Takahashi T (2007) Successful treatment with azathioprine for autoimmune thrombocytopenia developing after autologous peripheral blood stem cell transplantation. (Article in Japanese). Rinsho Ketsueki 48(8):637–641PubMedGoogle Scholar
  15. 15.
    Toltl LJ, Arnold DM (2011) Pathophysiology and management of chronic immune thrombocytopenia: focusing on what matters. Br J Haematol 152(1):52–60PubMedCrossRefGoogle Scholar
  16. 16.
    Wu Z, Zhou J, Pankaj P, Peng B (2011) Laparoscopic splenectomy for immune thrombocytopenia (ITP) patients with platelet counts lower than 1 × 109/L. Int J Hematol 94(6):533–538PubMedCrossRefGoogle Scholar

Copyright information

© Indian Society of Haematology & Transfusion Medicine 2012

Authors and Affiliations

  • Ahmet Emre Eskazan
    • 1
  • Ayse Salihoglu
    • 2
  • Emine Gulturk
    • 2
  • Seniz Ongoren Aydin
    • 2
  • Nukhet Tuzuner
    • 3
  • Yildiz Aydin
    • 2
  1. 1.Department of HematologyDiyarbakir Training and Research HospitalDiyarbakirTurkey
  2. 2.Division of Hematology, Department of Internal Medicine, Cerrahpasa Faculty of MedicineIstanbul UniversityIstanbulTurkey
  3. 3.Department of Pathology, Cerrahpasa Faculty of MedicineIstanbul UniversityIstanbulTurkey

Personalised recommendations